PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
268.00
-4.00 (-1.47%)
Apr 29, 2026, 9:36 AM WIB
IDX:DGNS Balance Sheet
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8,475 | 4,209 | 10,245 | 28,011 | 44,720 |
Short-Term Investments | 1,458 | 959.59 | 1,696 | 2,543 | 6,507 |
Cash & Short-Term Investments | 9,933 | 5,169 | 11,941 | 30,553 | 51,227 |
Cash Growth | 92.17% | -56.71% | -60.92% | -40.36% | 209.75% |
Accounts Receivable | 46,276 | 41,810 | 38,280 | 42,422 | 41,730 |
Other Receivables | 10,427 | 7,079 | 6,972 | 7,033 | 32,209 |
Receivables | 56,703 | 48,889 | 45,252 | 49,455 | 73,939 |
Inventory | 6,079 | 5,043 | 5,142 | 6,567 | 7,760 |
Prepaid Expenses | 357.75 | 275.79 | 194.89 | 266.08 | 784.92 |
Other Current Assets | 18,125 | 19,231 | 25,275 | 31,532 | 20,153 |
Total Current Assets | 91,198 | 78,608 | 87,805 | 118,373 | 153,864 |
Property, Plant & Equipment | 209,420 | 202,426 | 164,248 | 109,219 | 87,107 |
Long-Term Investments | 12,951 | 12,951 | 12,951 | 8,445 | - |
Other Intangible Assets | 1,670 | 1,353 | 720.43 | 681.12 | - |
Long-Term Deferred Tax Assets | 697.72 | 815.57 | 1,031 | 1,020 | 1,012 |
Other Long-Term Assets | 2,736 | 3,869 | 4,719 | 2,198 | - |
Total Assets | 318,672 | 300,022 | 271,475 | 239,936 | 241,983 |
Accounts Payable | 8,921 | 9,551 | 6,090 | 3,078 | 4,524 |
Accrued Expenses | 6,446 | 4,116 | 3,178 | 1,556 | 3,125 |
Current Portion of Long-Term Debt | 2,612 | 152.08 | - | 1,701 | - |
Current Portion of Leases | 4,394 | 5,012 | 3,710 | 1,811 | 2,390 |
Current Income Taxes Payable | 153.71 | 255.12 | 268.87 | 674.83 | 16,013 |
Current Unearned Revenue | 4,778 | 1,748 | 651.53 | 893.77 | - |
Other Current Liabilities | 310.34 | 772.59 | 545.72 | 777.24 | 576.26 |
Total Current Liabilities | 27,615 | 21,606 | 14,444 | 10,492 | 26,628 |
Long-Term Debt | 49,508 | 44,817 | 30,000 | 9,358 | - |
Long-Term Leases | 20,632 | 20,401 | 21,004 | 409.04 | 2,888 |
Long-Term Unearned Revenue | 6,800 | 7,820 | - | - | - |
Pension & Post-Retirement Benefits | 1,548 | 1,292 | 2,156 | 1,686 | 3,103 |
Other Long-Term Liabilities | 8,578 | 7,954 | 8,280 | 7,563 | 7,563 |
Total Liabilities | 114,682 | 103,890 | 75,885 | 29,508 | 40,182 |
Common Stock | 31,250 | 31,250 | 31,250 | 31,250 | 31,250 |
Additional Paid-In Capital | 36,707 | 36,707 | 36,707 | 36,707 | 36,707 |
Retained Earnings | 135,202 | 132,265 | 131,518 | 145,173 | 132,509 |
Comprehensive Income & Other | 831.26 | -4,090 | -3,884 | -2,702 | 1,335 |
Shareholders' Equity | 203,990 | 196,132 | 195,590 | 210,428 | 201,800 |
Total Liabilities & Equity | 318,672 | 300,022 | 271,475 | 239,936 | 241,983 |
Total Debt | 77,146 | 70,382 | 54,714 | 13,279 | 5,277 |
Net Cash (Debt) | -67,214 | -65,213 | -42,773 | 17,274 | 45,950 |
Net Cash Growth | - | - | - | -62.41% | 229.33% |
Net Cash Per Share | -53.77 | -52.17 | -34.22 | 13.82 | 37.04 |
Filing Date Shares Outstanding | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 |
Total Common Shares Outstanding | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 |
Working Capital | 63,582 | 57,002 | 73,361 | 107,881 | 127,236 |
Book Value Per Share | 163.19 | 156.91 | 156.47 | 168.34 | 161.44 |
Tangible Book Value | 202,320 | 194,779 | 194,870 | 209,747 | 201,800 |
Tangible Book Value Per Share | 161.86 | 155.82 | 155.90 | 167.80 | 161.44 |
Land | 60,802 | 54,643 | 43,655 | 43,655 | 43,655 |
Buildings | 82,773 | - | - | - | - |
Machinery | 48,586 | 46,447 | 44,285 | 39,548 | 31,771 |
Construction In Progress | 13,627 | 88,001 | 53,061 | 18,411 | 311.4 |
Leasehold Improvements | 27,721 | 27,857 | 26,026 | 23,672 | 14,201 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.